Neurizon Therapeutics (FRA:ECQ0) Change In Inventory : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics Change In Inventory?

Neurizon Therapeutics's change in inventory for the quarter that ended in Dec. 2024 was €0.00 Mil. It means Neurizon Therapeutics's inventory stayed the same from Jun. 2024 to Dec. 2024 .

Neurizon Therapeutics's change in inventory for the fiscal year that ended in Jun. 2005 was €0.00 Mil. It means Neurizon Therapeutics's inventory stayed the same from Jun. 2004 to Jun. 2005 .

Neurizon Therapeutics's Total Inventories for the quarter that ended in Dec. 2024 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Neurizon Therapeutics Change In Inventory Historical Data

The historical data trend for Neurizon Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Change In Inventory Chart

Neurizon Therapeutics Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun24

Change In Inventory

Get a 7-Day Free Trial

Neurizon Therapeutics Semi-Annual Data
	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Neurizon Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Neurizon Therapeutics (FRA:ECQ0) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Neurizon Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Neurizon Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Neurizon Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Neurizon Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

NUZ:Australia

Address

96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205

Website

https://www.neurizon.com

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines